Skip to content

Story: New Breakthrough May Lead to HIV Relapse Cure

  • Dorrit Walsh

October 2015 Examples of media coverage: New Breakthrough May Lead to HIV Relapse Cure – Indo-Asian News Service, October 11, 2015 HIV breakthrough could lead to a CURE: Scientists identify markers on immune cells that ‘predict who can stop drug…

Read more

The Challenge of Defining HIV Remission

  • Chad Cipiti

Supportive regulatory guidance for cure research requires a clear understanding of all possible outcomes, including remission By Richard Jefferys The term remission is increasingly being invoked in the context of cure research and, by extension, is an issue for regulatory…

Read more

PrEP: The Pathway to Global Access

  • Chad Cipiti

Regulatory filing and review delays keep Truvada as pre-exposure prophylaxis out of reach of those who need it most By Scott Morgan Pre-exposure prophylaxis (PrEP) is the use of antiretroviral medication to prevent HIV acquisition. The U.S. Food and Drug…

Read more

TAGline Fall 2015

  • Chad Cipiti

In Defense of Stringency: In response to growing public concern with health risks posed by approved drugs, a 2006 landmark report by the Institute of Medicine (IOM) argued that the U.S. Food and Drug Administration (FDA) lacks the unambiguous authority necessary to ensure the safety and efficacy of the country’s medicinal products.

Read more

2015 Pipeline Report

  • Chad Cipiti

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.

Read more

Story: Gilead Sciences May Have Found A Cure For HIV

  • Dorrit Walsh

May 2015 Examples of media coverage: Gilead Sciences (GILD) May Have Found A Cure For HIV! – CNA Finance, May 18, 2015 This Experimental Drug Could Finally Cure HIV – Motley Fool, May 18, 2015‎ Original source: Unknown, possibly a…

Read more
Back To Top